Overview

Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia

Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
This study is designed to compare the efficacy and drug tolerability of two strategies for the treatment of schizophrenia. The two strategies consist of utilizing, on the one hand, a conventional antipsychotic like haloperidol or flupentixol and, on the other hand, a newer antipsychotic compound like olanzapine, quetiapine or aripiprazole in patients with schizophrenia.
Phase:
Phase 4
Details
Lead Sponsor:
University of Bremen
Collaborator:
German Federal Ministry of Education and Research
Treatments:
Antipsychotic Agents
Aripiprazole
Flupenthixol
Flupenthixol decanoate
Haloperidol
Haloperidol decanoate
Olanzapine
Quetiapine Fumarate